The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.
G.W. Albers
Stanford Stroke Center
Palo Alto
USA
Name/email consistency: high
- Antithrombotic therapy in atrial fibrillation. Albers, G.W., Dalen, J.E., Laupacis, A., Manning, W.J., Petersen, P., Singer, D.E. Chest (2001)
- Antithrombotic and thrombolytic therapy for ischemic stroke. Albers, G.W., Amarenco, P., Easton, J.D., Sacco, R.L., Teal, P. Chest (2001)
- Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. Albers, G.W., Bates, V.E., Clark, W.M., Bell, R., Verro, P., Hamilton, S.A. JAMA (2000)
- Choice of endpoints in antiplatelet trials: which outcomes are most relevant to stroke patients?. Albers, G.W. Neurology (2000)
- Yield of diffusion-weighted MRI for detection of potentially relevant findings in stroke patients. Albers, G.W., Lansberg, M.G., Norbash, A.M., Tong, D.C., O'Brien, M.W., Woolfenden, A.R., Marks, M.P., Moseley, M.E. Neurology (2000)
- Dose escalation study of the NMDA glycine-site antagonist licostinel in acute ischemic stroke. Albers, G.W., Clark, W.M., Atkinson, R.P., Madden, K., Data, J.L., Whitehouse, M.J. Stroke (1999)
- Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection. Albers, G.W. Stroke (1999)
